Clinical Characteristics of a Second Small Nodule(s) Associated with cT1–2N0M0Non-Small-Cell Lung Cancer
✍ Scribed by Ho Il Yoon; Jae-Jun Yim; Choon-Taek Lee; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Young Tae Kim; Sook Whan Sung; Joo Hyun Kim; Chul-Gyu Yoo
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 57 KB
- Volume
- 184
- Category
- Article
- ISSN
- 0341-2040
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We examined the biologic properties of a small-cell-lungcarcinoma (SCLC) cell line (designated MN-I I 12) established from a patient with SCLC who showed paraneoplastic retinopathy syndrome. Morphologic and immunocytochemical analyses showed that MN-I I I2 cells possess features of the classic type
A total of 52 consecutive, previously untreated patients with small-cell lung cancer (SCLC) were scheduled to receive six cycles of a combination of etoposide (75 mg/m2 per day) and cisplatin (20 mg/m2 per day), each cycle given over 5 consecutive days. In all, 28 patients had extensive disease (ED)